Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Registry of patients with Takotsubo syndrome

Official title: The GErman Italian Spanish Takotsubo (GEIST) Registry

Run by University of Luebeck · NCT04361994 · Data updated 2026-11-12

This study collects detailed information about people with Takotsubo syndrome to better understand their experiences and health outcomes over time.

More Takotsubo Cardiomyopathy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorUniversity of Luebeck
Academic / other
Locations2 sites (Lübeck, Schleswig-Holstein and 1 other locations)
StatusRecruiting
StartedApril 2015
Main results expectedDecember 2035
Study endsDecember 2035
Registry record updatedDecember 26, 2025
Trial IDNCT04361994 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are individuals diagnosed with Takotsubo syndrome.

Probably not a fit

Patients with conditions other than Takotsubo syndrome will not benefit from participation in this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The GEIST registry is a multicenter, international observational initiative that collects comprehensive data on patients diagnosed with Takotsubo syndrome. It gathers information on clinical profiles, in-hospital courses, complications, and both short- and long-term outcomes through a combination of prospective and retrospective data collection methods. This includes structured telephone interviews for long-term follow-up, ensuring a thorough understanding of the disease's impact on patients.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding of Takotsubo syndrome, leading to improved diagnosis and management strategies for patients.

How similar studies have gone: Other observational registries have shown success in improving understanding and management of similar cardiac conditions, suggesting that this approach could be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with Takotsubo syndrome

Exclusion Criteria:

* Non

Where it's running

  • Universität zu Lübeck
    Lübeck, Schleswig-Holstein, Germany
    Recruiting
  • University of Foggia
    Foggia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.